ELFABRIO
pegunigalsidase alfa
- Strength
- 5 mg/2.5mL
- Form
- Injection, Solution, Concentrate
Chiesi USA, Inc.
Not stocked by us — reference only
pegunigalsidase alfa
Listed by Chiesi USA, Inc.
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 10122-160 |
| FDA application | BLA761161 |
| RxNorm concept | 2637456 |
| Package sizes listed | 3 |
| Marketed since | May 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
pegunigalsidase alfa
Chiesi USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.